114 related articles for article (PubMed ID: 27056103)
1. A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients.
Noer MC; Sperling CD; Antonsen SL; Ottesen B; Christensen IJ; Høgdall C
Gynecol Oncol; 2016 Jun; 141(3):471-478. PubMed ID: 27056103
[TBL] [Abstract][Full Text] [Related]
2. Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients - a comparative cohort study.
Noer MC; Leandersson P; Paulsen T; Rosthøj S; Antonsen SL; Borgfeldt C; Høgdall C
Acta Oncol; 2018 Aug; 57(8):1100-1108. PubMed ID: 29451070
[TBL] [Abstract][Full Text] [Related]
3. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay?
Noer MC; Sperling CD; Ottesen B; Antonsen SL; Christensen IJ; Høgdall C
Int J Gynecol Cancer; 2017 Jul; 27(6):1123-1133. PubMed ID: 28604447
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a comorbidity scoring system for patients with cirrhosis.
Jepsen P; Vilstrup H; Lash TL
Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
[TBL] [Abstract][Full Text] [Related]
6. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
[TBL] [Abstract][Full Text] [Related]
7. Secondary validation of an ovarian cancer-specific comorbidity index in a US population.
Vranes C; Zhao H; Noer MC; Fu S; Sun CC; Harrison R; Ramirez PT; Høgdall CK; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2023 May; 33(5):749-754. PubMed ID: 36863760
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity is an independent prognostic factor for the survival of ovarian cancer: a Danish register-based cohort study from a clinical database.
Sperling C; Noer MC; Christensen IJ; Nielsen ML; Lidegaard Ø; Høgdall C
Gynecol Oncol; 2013 Apr; 129(1):97-102. PubMed ID: 23290990
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study.
Tetsche MS; Nørgaard M; Jacobsen J; Wogelius P; Sørensen HT
Int J Gynecol Cancer; 2008; 18(3):421-7. PubMed ID: 17692093
[TBL] [Abstract][Full Text] [Related]
10. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
Engelhardt M; Domm AS; Dold SM; Ihorst G; Reinhardt H; Zober A; Hieke S; Baayen C; Müller SJ; Einsele H; Sonneveld P; Landgren O; Schumacher M; Wäsch R
Haematologica; 2017 May; 102(5):910-921. PubMed ID: 28154088
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity is an independent prognostic factor in women with uterine corpus cancer: a nationwide cohort study.
Noer MC; Sperling C; Christensen IJ; Nielsen ML; Lidegaard O; Høgdall C
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):325-34. PubMed ID: 24443826
[TBL] [Abstract][Full Text] [Related]
13. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
14. Predictive ability of Charlson comorbidity index on outcomes from lung cancer.
Ganti AK; Siedlik E; Marr AS; Loberiza FR; Kessinger A
Am J Clin Oncol; 2011 Dec; 34(6):593-6. PubMed ID: 21217398
[TBL] [Abstract][Full Text] [Related]
15. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients.
Jørgensen TL; Teiblum S; Paludan M; Poulsen LØ; Jørgensen AY; Bruun KH; Hallas J; Herrstedt J
Gynecol Oncol; 2012 Nov; 127(2):367-74. PubMed ID: 22800653
[TBL] [Abstract][Full Text] [Related]
16. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.
Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK
Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586
[TBL] [Abstract][Full Text] [Related]
17. Development of an epilepsy-specific risk adjustment comorbidity index.
St Germaine-Smith C; Liu M; Quan H; Wiebe S; Jette N
Epilepsia; 2011 Dec; 52(12):2161-7. PubMed ID: 22004000
[TBL] [Abstract][Full Text] [Related]
18. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study.
Lin HW; Tu YY; Lin SY; Su WJ; Lin WL; Lin WZ; Wu SC; Lai YL
Lancet Oncol; 2011 Sep; 12(9):900-4. PubMed ID: 21835693
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
[TBL] [Abstract][Full Text] [Related]
20. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.
Kannegaard PN; van der Mark S; Eiken P; Abrahamsen B
Age Ageing; 2010 Mar; 39(2):203-9. PubMed ID: 20075035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
